Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Network bioinformatics analysis provides insight into drug repurposing for COVID-19

30 Mar 2021

Abstract excerpt

The COVID-19 disease caused by the SARS-CoV-2 virus is a health crisis worldwide. While developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 can yield treatments with known preclinical, pharmacokinetic, pharmacodynamic, and toxicity profiles, which can rapidly enter clinical trials. In this study, we present a novel network-based drug repurposing platform to identify candidates...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to COVID-19 Clinical Research Studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33817623
DOI: 10.1016/j.medidd.2021.100090

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Network bioinformatics analysis provides insight into drug repurposing for COVID-19PMID 33817623Read ↗

Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysisSemantic proximity Read ↗

A Connectivity Map-Based Drug Repurposing Study and Integrative Analysis of Transcriptomic Profiling of SARS-CoV-2 InfectionSemantic proximity Read ↗

Drug Target Set Enrichment Analysis (DTSEA): A Network-Based Approach for Drug Repurposing to COVID-19Semantic proximity Read ↗

In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic DataSemantic proximity Read ↗

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19Semantic proximity Read ↗

Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approachSemantic proximity Read ↗

A Network-Biology Led Computational Drug Repurposing Strategy to Prioritize Therapeutic Options for COVID-19Semantic proximity Read ↗

Drug Repurposing of potential drug targets for treatment of COVID-19Semantic proximity Read ↗

A Network-Biology led Computational Drug repurposing Strategy to prioritize therapeutic options for COVID-19Semantic proximity Read ↗

The COVID-19 PHARMACOME: A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonizationSemantic proximity Read ↗

Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus–Host InteractomeSemantic proximity Read ↗

Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.